The Food and Drug Administration today authorized the Moderna and Pfizer bivalent COVID-19 vaccines for emergency use in children as young as 6 months old. Specifically, the agency authorized the Moderna vaccine as a single booster dose for children aged 6 months through 5 at least two months after primary vaccination, and the Pfizer vaccine for children aged 6 months through 4 who have not yet received the third primary series dose. Before providers can start administering the bivalent doses, the Centers for Disease Control and Prevention must recommend them for these age groups.

Related News Articles

Headline
The House March 5 voted 382-12 to pass the AHA-supported Preventing Maternal Deaths Reauthorization Act (H.R. 3838), bipartisan legislation that would…
Headline
The House Energy and Commerce Subcommittee on Health Feb. 29 held a hearing on legislative proposals to expand access to treatment for patients with rare…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Part of a special series exploring how hospitals and health systems are addressing the medical complications that can accompany pregnancy, this podcast shares…
Headline
Iowa, Massachusetts, Maryland, Michigan, Minnesota and New Mexico will participate in a new Department of Health and Human Services collaborative that will…
Headline
The Department of Health and Human Services Feb. 14 named several hospital and health system programs final phase winners in its national competition to…